John Kirwan, director of the Metabolic Translational Research Center and professor of molecular medicine at the Cleveland Clinic, has been named executive director of the Pennington Biomedical Research Center at LSU.
The appointment of Kirwan is pending approval by the LSU Board of Supervisors. who will vote on the matter on Friday. If approved, I would start work on January 1.
LSU President F. King Alexander praised Kirwan's outstanding record in diabetes research and said that made it perfect for Pennington.
"I am excited to see the effect that your leadership has on the center's existing efforts to improve health outcomes for Louisiana citizens and their already stellar research portfolio," said Alexander.
Kirwan will succeed Dr. Donna Ryan, who has been serving as interim executive director of Pennington. She replaced Dr. William T. Cefalu, who left Pennington in February after nearly five years as executive director to become the scientific and medical director of the American Diabetes Association.
Kirwan is also professor of physiology and nutrition at Case School of Medicine at Western Reserve University in Cleveland. His professional experience includes almost 30 years of research, teaching and service in the fields of obesity and diabetes.
"As the pandemic of chronic diseases and obesity attract more attention internationally, Pennington Biomedical is well positioned to be a leader in clinical research on these issues, as well as discover new treatments and provide support to support lifestyles more healthy, "said Kirwan.
Kirwan received his training in clinical physiology from the University of Washington School of Medicine in St. Louis; his Ph.D. in human bioenergetics at Ball State University in Muncie, Indiana; his masters in exercise biochemistry from the University of Massachusetts at Amherst; and his bachelor's degree from the University of Limerick, Ireland.
Kirwan leads an internationally acclaimed biomedical research program focused on diabetes, obesity, nutrition and exercise. He has published more than 200 scientific articles related to diabetes and metabolism in prestigious peer-reviewed journals, including the New England Journal of Medicine, JAMA, Diabetes and Diabetes Care. Among his most important research contributions is the discovery that, for a significant number of patients, diabetes can be remitted in the long term by surgically altering the physiology of the intestine and stomach.
Follow Timothy Boone on Twitter, @TCB_TheAdvocate. [1